Active Needle is dedicated to exploiting the properties of ultrasonically Active Needles. The technology allows the products to have potential applications in a range of multi-billion pound markets. These global markets could include healthcare and life sciences & medical and non-medical tattooing.
We believe ultrasonic energy can convey amazing properties to needles. Active Needle Technology (ANT) is dedicated to the exploitation of these properties. Our team of experienced professionals have helped develop a range of products in multi-billion pound markets. In medicine, life science and veterinary applications, ultrasonically energised needles could convey improved visibility for needles in scans. In tattooing, ultrasonic needles may have the potential to reduce pain and swelling.
The company’s lead medical product, a biopsy system, recently received CE mark, which opens the way to sales. Patent grants in China, Japan, and South Korea have been achieved, with others pending.
Development is nearing completion on the company’s life science needle which was developed with the support of AstraZeneca, GlaxoSmithKline and the University of Sheffield. We are in early stage discussions over a distribution partnership.
ANT has recently won a UK grant competition for £220k to productionize, what we believe, is the world’s first ultrasonic tattoo machine. The patent for this product has now been filed in numerous countries.
Poised on the edge of commercialisation, the company is now ready for sales. For investors, the opportunity is to join an exciting, market-ready company with patented, potentially game-changing devices aiming to enter high-value international markets.